These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
134 related items for PubMed ID: 7046927
1. Therapy for patients with acute myelocytic leukemia who enter remission: bone marrow transplantation or chemotherapy? Preisler HD. Cancer Treat Rep; 1982 Jul; 66(7):1467-73. PubMed ID: 7046927 [No Abstract] [Full Text] [Related]
2. The role of intensive postinduction chemotherapy in the management of patients with acute myelogenous leukemia. Mayer RJ, Weinstein HJ, Coral FS, Rosenthal DS, Frei E. Cancer Treat Rep; 1982 Jul; 66(7):1455-62. PubMed ID: 7046925 [No Abstract] [Full Text] [Related]
3. Busulfan plus etoposide as a preparative regimen for autologous bone marrow transplantation for acute myelogenous leukemia: an update. Linker CA, Damon LE, Ries CA, Rugo HS, Wolf JL. Semin Oncol; 1993 Aug; 20(4 Suppl 4):40-8; quiz 49. PubMed ID: 8342075 [Abstract] [Full Text] [Related]
4. [Comparison between bone marrow autograft and intensive chemotherapy as treatment for maintenance of complete remission in acute myeloblastic leukemia in the adult. GOELAM Group]. Harousseau JL, Pignon B, Cahn JY. Nouv Rev Fr Hematol (1978); 1993 Jun; 35(3):197-8. PubMed ID: 8337124 [No Abstract] [Full Text] [Related]
5. Strategies for acute myelogenous leukemia. Gale RP, Butturini A. Bone Marrow Transplant; 1991 Jun; 7 Suppl 2():58. PubMed ID: 1878721 [No Abstract] [Full Text] [Related]
6. Comparative trials of chemotherapy and bone marrow transplantation in acute nonlymphocytic leukemia. Sullivan KM, Appelbaum FR. Rinsho Ketsueki; 1990 May; 31(5):527-33. PubMed ID: 2118573 [No Abstract] [Full Text] [Related]
7. The therapy of acute myelogenous leukemia, a major challenge of onco-hematology. Boiron M. Pathol Biol (Paris); 1986 Mar; 34(3):153-6. PubMed ID: 3517783 [No Abstract] [Full Text] [Related]
8. Results of syngeneic hematopoietic stem cell transplantation for acute leukemia: risk factors for outcomes of adults transplanted in first complete remission. Fouillard L, Labopin M, Gratwohl A, Gluckman E, Frassoni F, Beelen DW, Willemze R, Montserrat E, Blaise D, Atienza AI, Sierra J, Santos M, Gorin NC, Rocha V, Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Haematologica; 2008 Jun; 93(6):834-41. PubMed ID: 18469352 [Abstract] [Full Text] [Related]
9. [Bone marrow transplantation in the treatment of acute leukemias]. Moiseev SI, Ganapiev AA, Abdulkadyrov KM. Ter Arkh; 1996 Jun; 68(12):8-10. PubMed ID: 9054052 [Abstract] [Full Text] [Related]
10. Treatment of acute myeloid leukaemia in first remission--chemotherapy versus bone marrow transplantation. De Witte T, De Pauw B, Holdrinet R, Janssen J, Haanen C. Neth J Med; 1985 Jun; 28(7):281-4. PubMed ID: 3897880 [No Abstract] [Full Text] [Related]
11. [Bone marrow transplantation versus maintenance chemotherapy for adult acute leukemia in first remission]. Suzuki R, Iida H, Taji H, Murata M, Sugihara T, Minami S, Kodera Y. Rinsho Ketsueki; 1996 Dec; 37(12):1362-70. PubMed ID: 8997123 [Abstract] [Full Text] [Related]
13. [Acute myeloid leukemia. Achievements and challenges in the treatment of adults]. Gruber A, Björkholm M. Lakartidningen; 1997 Jun 25; 94(26-27):2454-6, 2459-60. PubMed ID: 9235443 [No Abstract] [Full Text] [Related]
14. Stage-specific application of allogeneic and autologous marrow transplantation in the management of acute myeloid leukemia. Edenfield WJ, Gore SD. Semin Oncol; 1999 Feb 25; 26(1):21-34. PubMed ID: 10073559 [Abstract] [Full Text] [Related]
15. [The success of lymphocyte infusion as treatment of leukemia recurrence following allogeneic bone marrow transplantation depends on low percentage of patient's own lymphocytes]. Schattenberg AV, van de Wiel-van Kemenade E, Bär BM, Geurts van Kessel AH, van der Maazen RW, de Witte TJ. Ned Tijdschr Geneeskd; 1996 Oct 19; 140(42):2087-91. PubMed ID: 8965951 [Abstract] [Full Text] [Related]
16. [Application of IHW2 purged bone marrow to autologous bone marrow transplantation in the treatment of acute myeloid leukemia]. Jiang R, Han M, Zhao Y. Zhonghua Xue Ye Xue Za Zhi; 1998 Jun 19; 19(6):312-4. PubMed ID: 11243113 [Abstract] [Full Text] [Related]
17. The changing pattern of therapy in adults with acute myeloblastic leukaemia. Jacobs P. Haematologica; 1981 Dec 19; 66(6):803-34. PubMed ID: 6802721 [No Abstract] [Full Text] [Related]
18. Increased myeloid precursors in regenerating bone marrow; implications for detection of minimal residual disease in acute myeloid leukemia. Zeleznikova T, Stevulova L, Kovarikova A, Babusikova O. Neoplasma; 2007 Dec 19; 54(6):471-7. PubMed ID: 17949229 [Abstract] [Full Text] [Related]
19. Allogeneic bone marrow transplantation for children with acute leukemia: long-term follow-up of patients prepared with high-dose cytosine arabinoside and fractionated total body irradiation. Gordon BG, Warkentin PI, Strandjord SE, Abromowitch M, Bayever E, Harper JL, Coccia PF. Bone Marrow Transplant; 1997 Jul 19; 20(1):5-10. PubMed ID: 9232249 [Abstract] [Full Text] [Related]
20. Long-term follow-up of patients undergoing allogeneic bone marrow transplantation for acute myeloid leukemia in first complete remission after cyclophosphamide-total body irradiation and cyclosporine. Mehta J, Powles R, Treleaven J, Horton C, Tait D, Meller S, Pinkerton CR, Middleton G, Eisen T, Singhal S. Bone Marrow Transplant; 1996 Oct 19; 18(4):741-6. PubMed ID: 8899189 [Abstract] [Full Text] [Related] Page: [Next] [New Search]